Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Extension of the LOCKCYST Trial, LOCKCYST: Long Acting Lnareotide as as Volume Reducing Treatment of Polycystic Livers

NCT00771888 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT00771888
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00771888 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Extension of the LOCKCYST Trial, LOCKCYST: Long Acting Lnareotide as as Volume Reducing Treatment of Polycystic Livers
Lead sponsor
Radboud University Medical Center
Phase
Phase 2/3
Overall status
Unknown status
Start date
April 30, 2008
Completion date
August 31, 2009
Enrollment
54 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

autosomal dominant, hepatomegaly, liver diseases, polycystic kidney, polycystic liver disease